NCT05925699

Brief Summary

The primary aim of the study is to develop a national registry of cerebrovascular diseases in order to define the subtypes of these diseases associated with a worse prognosis. Secondly, the study aims to find clinical, radiological, and biological markers capable tof predicting the outcome of cerebrovascular diseases and the onset of complications related to therapeutic procedures, and to calculate predictive prognostic scores composed of multiple variables. Each participating center will collect clinical, radiological, and biological data from the medical records of the study participants. Patients included in the study will not undergo any additional medical procedures to those of normal clinical practice.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
285,600

participants targeted

Target at P75+ for all trials

Timeline
320mo left

Started Sep 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Sep 2023Sep 2052

First Submitted

Initial submission to the registry

June 9, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 29, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
29 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2052

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2052

Last Updated

July 13, 2023

Status Verified

July 1, 2023

Enrollment Period

29 years

First QC Date

June 9, 2023

Last Update Submit

July 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identification of subtypes of each cerebrovascular disease (ICD-9 430-438) associated with poor prognosis.

    Identification and definition of the various subtypes of each cerebrovascular disease (International Classification of Diseases, 9th revision (ICD-9): ICD-9 430-438) associated with poor prognosis.

    July 1, 2023 - July 1, 2053

Secondary Outcomes (20)

  • Identification of clinical variables of each cerebrovascular disease correlated with its prognosis

    July 1, 2023 - July 1, 2053

  • Identification of radiological variables of each cerebrovascular disease correlated with its prognosis

    July 1, 2023 - July 1, 2053

  • Identification of biomarkers of each cerebrovascular disease correlated with its prognosis

    July 1, 2023 - July 1, 2053

  • Identification of neurophysiological variables of each cerebrovascular disease correlated with its prognosis

    July 1, 2023 - July 1, 2053

  • Identification of prognostic scores for each cerebrovascular disease

    July 1, 2023 - July 1, 2053

  • +15 more secondary outcomes

Study Arms (1)

All patients with new-onset cerebrovascular disease from January 1, 2016 to July 1, 2049

Other: Collection of clinical, radiological, and biological data from patients' medical records

Interventions

Collection of clinical, radiological, and biological data from patients' medical records

All patients with new-onset cerebrovascular disease from January 1, 2016 to July 1, 2049

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with cerebrovascular diseases occuring between January 1, 2016 and July 1, 2049 who consented to partecipate in the study

You may qualify if:

  • Diagnosis of cerebrovascular pathology defined according to the NINDS special report of 1990 as "all disorders in which there is an area of the brain transiently or permanently affected by ischemia or bleeding and/or in which one or more blood vessels of the brain are mainly altered by a pathological process", falling within the following codes of the International Classification of Diseases, 9th revision (ICD-9): ICD-9 430-438;
  • Informed consent provided by the patient or his legal representative in the case of mental incapacity or by the parents/guardians in the case of minors.

You may not qualify if:

  • The patient, his legal representative in the case of mental incapacity or his parents/guardians in the case of minors clearly state their will to leave the study;
  • Onset of cerebrovascular disease before January 1, 2016.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Rome, Lazio, 00168, Italy

Location

Related Publications (6)

  • Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke. 1990 Apr;21(4):637-76. doi: 10.1161/01.str.21.4.637. No abstract available.

  • Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, Gale CP, Maggioni AP, Petersen SE, Huculeci R, Kazakiewicz D, de Benito Rubio V, Ignatiuk B, Raisi-Estabragh Z, Pawlak A, Karagiannidis E, Treskes R, Gaita D, Beltrame JF, McConnachie A, Bardinet I, Graham I, Flather M, Elliott P, Mossialos EA, Weidinger F, Achenbach S; Atlas Writing Group, European Society of Cardiology. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022 Feb 22;43(8):716-799. doi: 10.1093/eurheartj/ehab892.

  • GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021 Oct;20(10):795-820. doi: 10.1016/S1474-4422(21)00252-0. Epub 2021 Sep 3.

  • Sacco S, Stracci F, Cerone D, Ricci S, Carolei A. Epidemiology of stroke in Italy. Int J Stroke. 2011 Jun;6(3):219-27. doi: 10.1111/j.1747-4949.2011.00594.x.

  • Ozpinar A, Mendez G, Abla AA. Epidemiology, genetics, pathophysiology, and prognostic classifications of cerebral arteriovenous malformations. Handb Clin Neurol. 2017;143:5-13. doi: 10.1016/B978-0-444-63640-9.00001-1.

  • Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep. 2019 Aug 23;19(10):74. doi: 10.1007/s11910-019-0988-x.

MeSH Terms

Conditions

Cerebrovascular Disorders

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Head of Neurology Department

Study Record Dates

First Submitted

June 9, 2023

First Posted

June 29, 2023

Study Start

September 1, 2023

Primary Completion (Estimated)

September 1, 2052

Study Completion (Estimated)

September 1, 2052

Last Updated

July 13, 2023

Record last verified: 2023-07

Locations